Month: January 2023

January 17, 2023

New recurring spotlight in MyVUMC will help address common questions about MyWorkday

A new regular feature — “MyWorkday Featured FAQs” — will address some of the most commonly asked or most important questions regarding the MyWorkday project.

By VUMC News and Communications
January 17, 2023

Vanderbilt Kennedy Center seeks adults 18-30 to study effects of noise on brain activity

The Vanderbilt Kennedy Center is seeking adult participants (ages 18 to 30) for a research study investigating the effects of different noise conditions on brain activity during the Attentional Network Task.

By VUMC News and Communications
January 17, 2023

Virtual REDCap event set for Feb. 1-3

The third annual Virtual REDCap Day event will be held via Zoom on Feb. 1-3 from 8 a.m.-11 a.m. CST each day. 

By VUMC News and Communications
Jeffrey Rathmell, PhD, left, and Kelsey Voss, PhD, led a multidisciplinary team that identified iron metabolism in T cells as a potential target for treating lupus.
January 13, 2023

Study identifies potential new approach for treating lupus

A Vanderbilt study found that targeting iron metabolism in immune system cells may offer a new approach for treating systemic lupus erythematosus — the most common form of the chronic autoimmune disease lupus.

By Leigh MacMillan
January 12, 2023

VUMC in the news, Jan. 17, 2023

Dominic Gamez is resuming more activities since he received an expandable prosthesis to treat osteosarcoma in his left leg.
January 12, 2023

Expandable prosthesis gives young patient more mobility

To treat the osteosarcoma in his left leg, Dominic Gamez, 7, and his family chose to have a magnetic expandable prosthesis implanted that can be manipulated to grow incrementally as the child grows.

By Nancy Humphrey
January 12, 2023

Antibody “fingerprinting” method potential advance to slow spread of dengue

Vanderbilt researchers have reported a major advance in understanding and potentially preventing dengue, a devastating, mosquito-borne tropical viral infection that is spreading across the globe.
By Bill Snyder
January 12, 2023

Chan Zuckerberg Initiative grant supports single-cell study of rare inherited disease

A multidisciplinary team led by Vanderbilt University Medical Center investigator Alexander Bick, MD, PhD, has been awarded a $2 million, four-year grant to study inflammation at the single-cell level in the rare disease RUNX1-FPD.
By Leigh MacMillan
January 12, 2023

Program at VUH seeks to improve medication safety

Vanderbilt Nursing and the Department of Pharmaceutical Services have teamed up to create the Medication Safety Champions program, intended to improve medication safety throughout Vanderbilt University Hospital.
By Matt Batcheldor
January 12, 2023

Study may lead to new diabetes, heart disease treatments

Vanderbilt research found that deletion of an autophagy-participating factor named PIK3C3 from the fat cells of mice led to compromised body temperature control, abnormal blood lipid levels, fatty liver and diabetes.
By Bill Snyder
January 12, 2023

Clinical trial compares different therapies for spine pain

A Vanderbilt clinical trial to determine whether multidisciplinary biopsychosocial intervention or individualized postural therapy intervention improved disability and reduced health care spending in patients with acute or subacute spine pain.
By Danny Bonvissuto
January 12, 2023

Sharp named Southern Surgical Association president

Vanderbilt's Kenneth Sharp, MD, has been named president of the Southern Surgical Association (SSA).
By Jill Clendening
1 … 3 4 5 6 7 8